Blood Preparation Market by Product (Whole Blood, Blood Components, and Blood Derivatives); By Type (Platelet Aggregation Inhibitors, Fibrinolytics, and Anticoagulants); By Application (Thrombocytosis, Pulmonary Embolism, Renal Impairment, Angina Blood Vessel Complications, and Others); By Geography (North America, Asia-Pacific, Europe, South America, and RoW),Industry Analysis, COVID-19 Impact Analysis, Size, Share, Growth, Trends, and Forecasts 2021-2028

Market Overview

The global Blood Preparation market size is estimated at 60.81 billion USD with a CAGR of 7.9% during the forecasted period from 2021-2028.

A body fluid in humans that transports vital constituents such as nutrients and oxygen to the cells and passages metabolic waste products from cells. Blood contains different constituents such as platelets, red blood cells, etc. which need to be stored at varied conditions for therapeutic efficiency.

The key factors propelling the growth of global Blood Preparation market are the rising demand for blood transfusions and growing occurrence of thrombocytosis-associated disorders. There is a high need for blood during surgical procedures. In addition, snowballing research and development activities in medical sector along with a rise in funding is expected to positively impact this market.

Also, rising plans by the government to expand blood preparation is fostering the market size during the forecast period. Moreover, there are blood donation camps organized which are likely to influence blood preparation. Further high-tech innovations along with commercialization of drugs are estimated to uplift the market.

On the other hand, one of the major factors constraining the Blood Preparation market is owed to growing transmission of disease such as HIV, viral fever, etc. in blood preparation. Also, mounting frequency of allergic reactions while blood transfusion such as hypotensive transfusion reaction is limiting the growth of this market.

Market Dynamics

The growing demand for blood transfusion amongst emergency departments in hospitals, rise in blood disorders such as thrombocytosis and the snowballing requirement for blood during accidents and surgical procedures are the major factors driving the growth of the global blood preparation market. However, during blood transfusion, the chances of transmission of diseases such as viral hemorrhagic fever, HIV, and Hepatitis B are high which may hamper the market from growing. Moreover, the introduction of innovative technologies along with the growing usage of plasma in pharmaceutical industry, and many governments across the globe are focusing on increasing the number of blood donations by applying reimbursement policies, such as monetary incentives for donors is likely to gain significant impetus for the blood preparation market share in the coming years.

Market Segmentation

The study provides a crucial view of the blood preparation by segmenting the market based on the product, type, application, and geography. The product segment includes whole blood, blood components, and blood derivatives. Platelet aggregation inhibitors, fibrinolytics, and anticoagulants are the classification of the type segment. By application segment, the segmentation comprises of thrombocytosis, pulmonary embolism, renal impairment, angina blood vessel complications, and others. Furthermore, geographical coverage has been offered for each of the major regions including North America, Asia-Pacific, Europe, Row, and South America.

Scope of the Global Blood Preparation Market

By Product

• Whole Blood
  • Red Cells
  • Plasma
  • Platelets
  • Granulocytes
• Blood Components
  • Packed Red Cells
  • Frozen Plasma
  • Whole Blood Components
  • Platelet Concentrate
  • Leukocyte Reduced Red Blood Cells
• Blood Derivative

By Type

• Platelet Aggregation Inhibitors
  • ADP Inhibitors
  • Glycoprotein Inhibitors
  • COX Inhibitors
  • Others
• Fibrinolytics
  • Streptokinase
  • Urokinase
  • Tissue Plasminogen Activator (tPA)
• Anticoagulants
  • Heparins
  • Direct Thrombin Inhibitors
  • Direct Factor Xa Inhibitors
  • Vitamin K Antagonists

By Application

• Thrombocytosis
• Pulmonary Embolism
• Infectious Disease
• Angina Blood Vessel Complications
• Other Applications

By Geography

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Korea
  • Rest of APAC
• South America
  • Brazil
  • Rest of South America
• Rest of the World
  • Middle East
  • Africa

TABLE OF CONTENTS

Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Market Scope

Chapter 2 Research Methodology
2.1 Primary Research
2.2 Research Methodology
2.3 Assumptions & Exclusions
2.4 Secondary Data Sources

Chapter 3 Market Overview
3.1 Report Segmentation & Scope
3.2 Key Market Trends
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunities
3.3 Porter’s Five Forces Analysis
3.4 Market Share Analysis

Chapter 4 Global Blood Preparation Market by Product: Market Size and Forecast, 2018 – 2026
4.1 Introduction
4.1.1 Market Size and Forecast
4.2 Whole Blood
4.2.1 Market Size and Forecast
4.2.2 Red Cells
4.2.2.1 Market Size and Forecast
4.2.3 Plasma
4.2.3.1 Market Size and Forecast
4.2.4 Platelets
4.2.4.1 Market Size and Forecast
4.2.5 Granulocytes
4.2.5.1 Market Size and Forecast
4.3 Blood Components
4.3.1 Market Size and Forecast
4.3.2 Packed Red Cells
4.3.2.1 Market Size and Forecast
4.3.3 Frozen Plasma
4.3.3.1 Market Size and Forecast
4.3.4 Whole Blood Components
4.3.4.1 Market Size and Forecast
4.3.5 Platelet Concentrate
4.3.5.1 Market Size and Forecast
4.3.6 Leukocyte Reduced Red Blood Cells
4.3.6.1 Market Size and Forecast
4.4 Blood Derivative
4.4.1 Market Size and Forecast

Chapter 5 Global Blood Preparation Market by Type: Market Size and Forecast, 2018 – 2026
5.1 Introduction
5.1.1 Market Size and Forecast
5.2 Platelet Aggregation Inhibitors
5.2.1 Market Size and Forecast
5.2.2 ADP Inhibitors
5.2.2.1 Market Size and Forecast
5.2.3 Glycoprotein Inhibitors
5.2.3.1 Market Size and Forecast
5.2.4 COX Inhibitors
5.2.4.1 Market Size and Forecast
5.2.5 Others
5.2.5.1 Market Size and Forecast
5.3 Fibrinolytics
5.3.1 Market Size and Forecast
5.3.2 Streptokinase
5.3.2.1 Market Size and Forecast
5.3.3 Urokinase
5.3.3.1 Market Size and Forecast
5.3.4 Tissue Plasminogen Activator (tPA)
5.3.4.1 Market Size and Forecast
5.4 Anticoagulants
5.4.1 Market Size and Forecast
5.4.2 Heparins
5.4.2.1 Market Size and Forecast
5.4.3 Direct Thrombin Inhibitors
5.4.3.1 Market Size and Forecast
5.4.4 Direct Factor Xa Inhibitors
5.4.4.1 Market Size and Forecast
5.4.5 Vitamin K Antagonists
5.4.5.1 Market Size and Forecast

Chapter 6 Global Blood Preparation Market by Application: Market Size and Forecast, 2018 – 2026
6.1 Introduction
6.1.1 Market Size and Forecast
6.2 Thrombocytosis
6.2.1 Market Size and Forecast
6.3 Pulmonary Embolism
6.3.1 Market Size and Forecast
6.4 Infectious Disease
6.4.1 Market Size and Forecast
6.5 Angina Blood Vessel Complications
6.5.1 Market Size and Forecast
6.6 Other Applications
6.6.1 Market Size and Forecast

Chapter 7 Global Blood Preparation Market by Geography: Market Size and Forecast, 2018 – 2026
7.1 Introduction
7.1.1 Market Size and Forecast
7.2 North America
7.2.1 North America Market Size & Forecast, By Country
7.2.2 North America Market Size & Forecast, By Product
7.2.3 North America Market Size & Forecast, By Type
7.2.4 North America Market Size & Forecast, By Application
7.2.5 The U.S.
7.2.5.1 Market Size and Forecast
7.2.6 Canada
7.2.6.1 Market Size and Forecast
7.2.7 Mexico
7.2.7.1 Market Size and Forecast
7.3 Europe
7.3.1 Europe Market Size and Forecast, By Country
7.3.2 Europe Market Size and Forecast, By Product
7.3.3 Europe Market Size and Forecast, By Type
7.3.4 Europe Market Size and Forecast, By Application
7.3.5 UK
7.3.5.1 Market Size and Forecast
7.3.6 Germany
7.3.6.1 Market Size and Forecast
7.3.7 France
7.3.7.1 Market Size and Forecast
7.3.8 Italy
7.3.8.1 Market Size and Forecast
7.3.9 Spain
7.3.9.1 Market Size and Forecast
7.3.10 Rest of Europe
7.3.10.1 Market Size and Forecast
7.4 Asia-Pacific
7.4.1 Asia-Pacific Market Size and Forecast, By Country
7.4.2 Asia-Pacific Market Size and Forecast, By Product
7.4.3 Asia-Pacific Market Size and Forecast, By Type
7.4.4 Asia-Pacific Market Size and Forecast, By Application
7.4.5 India
7.4.5.1 Market Size and Forecast
7.4.6 China
7.4.6.1 Market Size and Forecast
7.4.7 Australia
7.4.7.1 Market Size and Forecast
7.4.8 Japan
7.4.8.1 Market Size and Forecast
7.4.9 South Korea
7.4.9.1 Market Size and Forecast
7.4.10 Rest of Asia-Pacific
7.4.10.1 Market Size and Forecast
7.5 South America
7.5.1 South America Market Size and Forecast, By Country
7.5.2 South America Market Size and Forecast, By Product
7.5.3 South America Market Size and Forecast, By Type
7.5.4 South America Market Size and Forecast, By Application
7.5.5 Brazil
7.5.5.1 Market Size and Forecast
7.5.6 Rest of South America
7.5.6.1 Market Size and Forecast
7.6 RoW
7.6.1 RoW Market Size and Forecast, By Country
7.6.2 RoW Market Size and Forecast, By Product
7.6.3 RoW Market Size and Forecast, By Type
7.6.4 RoW Market Size and Forecast, By Application
7.6.5 Middle East
7.6.5.1 Market Size and Forecast
7.6.6 Africa
7.6.6.1 Market Size and Forecast

Chapter 8 Company Profiles
8.1 AstraZeneca Co
8.2 Baxter Healthcare Corp.
8.3 Bristol-Myers Squibb Co.
8.4 Celgene Corp
8.5 GlaxoSmithKline PLC
8.6 Leo Pharma Inc.
8.7 Pfizer Inc.
8.8 Sanofi Aventis
8.9 Shandong East Chemical Industry Co.

Blood Preparation Market Key Players

• AstraZeneca Co
• Baxter Healthcare Corp.
• Bristol-Myers Squibb Co.
• Celgene Corp
• GlaxoSmithKline PLC
• Leo Pharma Inc.
• Pfizer Inc.
• Sanofi Aventis
• Shandong East Chemical Industry Co.